Boston, MA, United States of America
Acetylon Pharmaceuticals, Inc.
Patents = 34
Forward Citations = 269
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
40 inventors (with patents filed for the assignee):
Acetylon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of selective histone deacetylase (HDAC) inhibitors for the treatment of cancer and other diseases. Their mission is to develop innovative therapies that target protein acetylation, a key process in cellular regulation. With a diverse pipeline and a commitment to scientific excellence, Acetylon Pharmaceuticals strives to improve patients' lives through their research and development efforts.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com